OR

Browse By

A Multicentre, Parallel Group Open-label Randomised Controlled Non-Inferiority Phase 3 Trial, of ceftolozane-tazobactam versus meropenem for definitive treatment [...] MERINO-3 (2019–2022)

Grant type:
Merck Sharp & Dohme Australia
Researchers:

  • Dr Adam Stewart

    ATH - Lecturer
    Royal Brisbane Clinical Unit
    Faculty of Medicine
    Higher Degree by Research Scholar
    UQ Centre for Clinical Research
    Faculty of Medicine
    ATH - Lecturer
    Royal Brisbane Clinical Unit
    Faculty of Medicine

  • Dr Patrick Harris

    Amplify Fellow
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
Merck, Sharp & Dohme